Fingerprint
Dive into the research topics of 'Pilot trial of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib plus carboplatin and paclitaxel in patients with stage IIIB or IV non-small-cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically